window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Partnerships & Funding

  • Biotech,Healthcare leadership,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics

    Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership

    Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

    February 20, 2026
  • Artificial Intelligence,Biotech,Drug discovery,Oncology,Partnerships & Funding,Research & Development,Technology and platforms

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    February 19, 2026
  • Artificial Intelligence,Biotech,Drug Development,Partnerships & Funding,Research & Development,Technology and platforms

    Nuclera and leadXpro partner on AI-guided workflow for membrane protein drug discovery

    Nuclera and leadXpro have entered a scientific partnership to develop [...]

    February 17, 2026
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding,Rare Diseases

    Kidswell Bio and Treehill Partners launch US newco to advance cell therapy for paediatric cerebral palsy

    Kidswell Bio and Treehill Partners have launched a US-based regenerative [...]

    February 16, 2026
  • Clinical Development,Drug Development,European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery

    Syngene International has entered a collaboration with Johns Hopkins University [...]

    February 12, 2026
  • Biotech,Clinical Development,Clinical Trials,Oncology,Partnerships & Funding

    Evogene licenses microbiome cancer therapy BMC128 to Shanghai Lishan Biopharmaceuticals

    Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]

    February 6, 2026
  • Cell & Gene Therapy,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    Affibody advances radioligand therapies for precision oncology

    On World Cancer Day (WCD), Affibody highlights its progress in [...]

    February 4, 2026
  • Cell & Gene Therapy,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    CuraCell highlights T-cell therapy advances for solid tumors on World Cancer Day

    On World Cancer Day (today, February 4), CuraCell highlights its [...]

    February 4, 2026
  • Biotech,Clinical Development,European biotech,Immunology,Oncology,Partnerships & Funding,Research & Development

    Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay

    Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]

    February 2, 2026
  • Chronic diseases,Digital Health,Medical devices,Partnerships & Funding

    M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic to establish Middle East automated insulin delivery centre

    M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic [...]

    February 2, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FairJourney Bio opens cryo-EM facility in San Diego for antibody discovery
    Categories: Biotech, Drug discovery, Facilities and infrastructure, Research & Development, Technology and platforms
  • Kinesin-2 motor variants shown to control cargo transport in neurons
    Categories: Neurosciences, Research & Development
  • Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome
    Categories: Central Nervous System, Clinical Development, Drug Delivery & Formulation, Drug Development, Neurosciences, Patient Centricity
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top